Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Tildrakizumab for Pediatric Psoriasis
Recruiting0 awardsPhase 2 & 3
Portland, Oregon
This trial has 3 parts. In the first part, researchers study how the drug affects adolescents. In the second part, they study how the drug affects younger children, and in the third part, they study how the drug affects children over the long term.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.